Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Posner Insider Profile
4 Followers
Christopher Posner, President & CEO, Director at Cara Therapeutics, holds 168.77K shares in Cara Therapeutics (Ticker: CARA).
Christopher Posner has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Posner's holdings
Insider Roles
President & CEO, Director
Roles that Christopher Posner holds in companies
Most Profitable Insider Trade
The most profitable trade made by Christopher Posner
Christopher Posner's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Posner's performance on stock
You May Also Like
Christopher Posner insider profile FAQ
What is the percentage of profitable transactions made by Christopher Posner?
The percentage of profitable transactions made by Christopher Posner is ―.
What is the average return per transaction made by Christopher Posner?
The average return per transaction made by Christopher Posner is ―.
What stocks does Christopher Posner hold?
Christopher Posner holds: CARA stocks.
What was Christopher Posner’s latest transaction?
Christopher Posner latest transaction was an Uninformative Sell of $1.06K.
What was Christopher Posner's most profitable transaction?
Christopher Posner’s most profitable transaction was an Informative Sell of CARA stock on November 23, 2020. The return on the trade was 10.30%.
What is Christopher Posner's role in Cara Therapeutics?
Christopher Posner's role in Cara Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.